Converge Biotech

Converge Enters India’s Generic Drug Market as an Innovative Company with the Primary Goal of Providing High-Quality and Affordable Generic Drugs to Customers. Our Strategic Cooperation with Global Participants in the Chronic Treatment Field Undoubtedly Acts as an Asset for Introducing Innovative Products into India. The Converge Team Possesses Outstanding Expertise and a Deep Understanding of the Global Pharmaceutical and Generic Drug Business. We Are Committed to Leveraging Our Global Expertise and Resources to Create Significant Value for Our Customers. The Launch of Converge Biotech Aims to Benefit Healthcare Providers and Patients, Who Can Experience the Use of High-Quality Generic Drugs Through Our Innovative Dosage and Packaging Options in the Chronic Care Field. Our Vision Is to Significantly Improve Patients’ Lives, and Converge’s Robust Pipeline of Non-Patented Products Covers All Major Therapeutic Areas and Dosage Forms While Focusing on Quality, Affordability, and Patient Needs Globally.